Edge Therapeutics (EDGE) News Today → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free EDGE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGlobal Metastatic Melanoma Therapeutics Market Anticipates Robust Growth with New Therapeutic Developmentsuk.finance.yahoo.com - March 28 at 12:35 AMIs Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Invest In Growth?finance.yahoo.com - March 27 at 9:33 AMCompanies Like Context Therapeutics (NASDAQ:CNTX) Could Be Quite Riskyfinance.yahoo.com - March 27 at 9:33 AMQ4 2023 Mink Therapeutics Inc Earnings Callau.finance.yahoo.com - March 22 at 12:34 AMMirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseasesfinance.yahoo.com - March 21 at 7:50 AMPhaxiam Therapeutics S.A.: PHAXIAM Announces 2023 Full-Year Results and Provides Business Updatefinanznachrichten.de - March 20 at 4:48 PMTempo Therapeutics Secures Series A Financing to Advance Cutting-Edge Tissue Scaffold Products into Clinical Trialsfinance.yahoo.com - March 19 at 10:13 PMContineum Therapeutics Seeks $150 Million IPO For MS Treatmentsseekingalpha.com - March 19 at 12:11 PMTelum Therapeutics appoints Dr. Subhendu Basu as CEOfinanznachrichten.de - March 19 at 7:10 AMBrenig Therapeutics Presented New Data for the Best-in-Class LRRK2 Inhibitor Targeting Parkinson's Disease at the ACS Spring 2024 Conferencefinance.yahoo.com - March 18 at 4:09 PMMonoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarketsfinanznachrichten.de - March 15 at 1:14 PMPioneering Protein Design A New Frontier in COVID-19 Therapeuticsmsn.com - March 15 at 8:14 AMLeading-Edge Technologies, Data and Insights: Bio-IT World Conference & Expo Highlights the Drivers of Precision Medicine Innovationfinance.yahoo.com - March 14 at 10:36 AMPrime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliancefinance.yahoo.com - March 13 at 8:30 AMPromising Future for Kymera Therapeutics: Analyst Endorses ‘Buy’ on Innovative Protein Degradation Compoundsmarkets.businessinsider.com - March 11 at 7:47 AMPromontory Therapeutics Enrolls 109 Patients in Prostate Cancer Studyfinance.yahoo.com - March 8 at 12:04 PMKyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosisfinance.yahoo.com - March 7 at 9:02 PMFierce Medtech Names Genesis Therapeutics a "Fierce 15" Company of 2023finance.yahoo.com - March 6 at 6:09 PMSonata Therapeutics and the Champalimaud Foundation Announce Research Collaboration for SNT-3012 in Pancreatic and Colorectal Cancersfinance.yahoo.com - March 5 at 11:42 AMAthos Therapeutics Announces the Autonomization of their Artificial Intelligence and Machine Learning Platformsfinance.yahoo.com - March 5 at 11:42 AMBetter Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lillymsn.com - March 5 at 6:41 AMMilestone marked as 200th company commits to Scottish EDGE Pledgemsn.com - March 4 at 7:00 AMBlue Earth Therapeutics Announces Participation in Upcoming B. Riley Securities Radiopharma Investor Conferencefinance.yahoo.com - February 28 at 12:24 PMUS Stocks Edge Higher; Domino's Posts Upbeat Earningsmsn.com - February 26 at 2:48 PMRAJANT HEALTH’S CUTTING-EDGE WEARABLE RECEIVES MEDICAL EXPERT ENDORSEMENTSmarkets.businessinsider.com - February 22 at 6:24 PMHealth-Care Stocks Edge Higher -- Health Care Roundupmarketwatch.com - February 16 at 7:16 PMGlobal Non Hodgkin Lymphoma Therapeutics Market Predicted to Reach $16.8 Billion by 2030 at a CAGR of 8.4%finance.yahoo.com - February 16 at 8:27 AM'I don't want pretty' - Relief and rejoicing as Stoke City edge QPR clashmsn.com - February 15 at 2:24 AMPrelude Therapeutics moves into new 100,000 square foot headquartersmsn.com - February 14 at 3:37 PMMicrosoft’s new Outlook requires you to have Edge installedmsn.com - February 13 at 2:04 PMPolaroid Therapeutics completes pre-clinical milestones in the development of superior antimicrobial technology for acute and chronic woundsfinance.yahoo.com - February 12 at 1:45 AMHere's Why We're Watching Arovella Therapeutics' (ASX:ALA) Cash Burn Situationfinance.yahoo.com - February 8 at 6:39 PMEdge of Ember Collaborates With Charlotte Collins on ‘70s-inspired Jewelry Collectionmsn.com - February 8 at 1:08 PMGlobal Melanoma Therapeutics Market Set for Remarkable Growth, Projected to Reach $6.16 Billion by 2028uk.finance.yahoo.com - February 8 at 1:08 PMBuy Rating for Denali Therapeutics Backed by Promising DNL310 Clinical Data and Accelerated Approval Potentialmarkets.businessinsider.com - February 8 at 3:08 AMVividion Therapeutics, Inc.: Vividion Therapeutics starts Phase I clinical trial in advanced solid and hematologic tumors with oral STAT3 inhibitorfinanznachrichten.de - February 6 at 1:35 PMVividion Therapeutics starts Phase I clinical trial in advanced solid and hematologic tumors with oral STAT3 inhibitorfinance.yahoo.com - February 6 at 1:35 PMStemson Therapeutics Announces Technological Breakthrough in New Hair Growthfinance.yahoo.com - February 6 at 1:35 PMWill Arecor Therapeutics (LON:AREC) Spend Its Cash Wisely?finance.yahoo.com - February 4 at 8:30 AMAprinoia Therapeutics Starts $50 Million IPO For Neurodegenerative Disease Treatmentsseekingalpha.com - February 2 at 7:27 PMKyverna Therapeutics targets up to $711 mln valuation in US IPOsg.finance.yahoo.com - February 1 at 10:42 AMResalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officerfinance.yahoo.com - February 1 at 10:42 AMMaxion Therapeutics Welcomes Dr Arndt Schottelius as New CEOfinance.yahoo.com - February 1 at 10:42 AMStock Market Today: Stocks edge higher ahead of massive week on Wall Streetthestreet.com - January 29 at 8:49 PMOverview of Sorrento Therapeutics' RTX (MCP-101, resiniferatoxin) Drug Across the 7MM, 2023-2032finance.yahoo.com - January 29 at 3:48 PMWhy Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionmsn.com - January 29 at 3:48 PMRebel's Edge - January 29: $SOFI, $MGRC, and the ACC Adds 3 Schoolsmsn.com - January 29 at 3:48 PMRactigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disordersfinance.yahoo.com - January 29 at 10:29 AMUS Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Dealmarkets.businessinsider.com - January 29 at 10:29 AMAsimov launches LV Edge Packaging System to optimize lentivirus productionfinance.yahoo.com - January 29 at 10:29 AM Get Edge Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EDGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Top Project Outperforms BTC in 2023… (Ad)According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024. Just click here for instant access to the #1 Coin for 2024. EDGE Media Mentions By Week EDGE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EDGE News Sentiment▼0.000.60▲Average Medical News Sentiment EDGE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EDGE Articles This Week▼48▲EDGE Articles Average Week Get Edge Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EDGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CytomX Therapeutics News Today I-Mab News Today PDS Biotechnology News Today Design Therapeutics News Today Adicet Bio News Today Spyre Therapeutics News Today Nuvectis Pharma News Today CervoMed News Today Genelux News Today Karyopharm Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EDGE) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edge Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.